Repeat Courses of SRS in Patients Initially Treated with SRS Alone for Brain-Metastatic Melanoma

References

• Gavrilovic IT , PosnerJB. Brain metastases: epidemiology and pathophysiology.J. Neurooncol.75 ( 1 ), 5 – 14 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Sperduto PW , ChaoST, SneedPKet al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int. J. Radiat. Oncol. Biol. Phys. 77 ( 3 ), 655 – 661 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sperduto PW , BerkeyB, GasparLE, MehtaM, CurranW. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.Int. J. Radiat. Oncol. Biol. Phys.70 ( 2 ), 510 – 514 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mori Y , KondziolkaD, FlickingerJC, KirkwoodJM, AgarwalaS, LunsfordLD. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.Int. J. Radiat. Oncol. Biol. Phys.42 ( 3 ), 581 – 589 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Rades D , SehmischL, HuttenlocherSet al. Radiosurgery alone for 1–3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes. Anticancer Res. 34 ( 9 ), 5079 – 5082 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Selek U , ChangEL, HassenbuschSJ3rdet al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int. J. Radiat. Oncol. Biol. Phys. 59 ( 4 ), 1097 – 1106 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Chang EL , WefelJS, HessKRet al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 10 ( 11 ), 1037 – 1044 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Brown PD , AsherAL, BallmanKVet al. NCCTG N0574 (alliance): a Phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases. J. Clin. Oncol. 33 ( Suppl ), Abstract LBA4 ( 2015 ).
   Google Scholar
• Fogarty G , MortonRL, VardyJet al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients – a randomised Phase III trial. BMC Cancer 11, 142 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Desantis CE , LinCC, MariottoABet al. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 64 ( 4 ), 252 – 271 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Postow MA , ChesneyJ, PavlickACet al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372 ( 21 ), 2006 – 2017 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Robert C , LongGV, BradyBet al. Nivolumab in previously untreated melanoma without BRAF mutation. N. Engl. J. Med. 372 ( 4 ), 320 – 330 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Robert C , RibasA, WolchokJDet al. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a Phase 1 trial. Lancet 384 ( 9948 ), 1109 – 1117 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Robert C , SchachterJ, LongGVet al. Pembrolizumab versus Ipilimumab in advanced melanoma. N. Engl. J. Med. 372 ( 26 ), 2521 – 2532 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hsu F , KouhestaniP, NguyenSet al. Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy. Radiother. Oncol. 108 ( 1 ), 128 – 131 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Shultz DB , ModlinLA, JayachandranPet al. Repeat courses of stereotactic radiosurgery (SRS), deferring whole-brain irradiation, for new brain metastases after initial SRS. Int. J. Radiat. Oncol. Biol. Phys. 92 ( 5 ), 993 – 999 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Press RH , PrabhuRS, NickleachDCet al. Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases. Cancer 121 ( 21 ), 3836 – 3843 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bates JE , YounP, UsukiKYet al. Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease. J. Neurooncol. 125 ( 2 ), 411 – 418 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Biswas T , SandhuAP, SinghDPet al. Low-dose radiosurgery for benign intracranial lesions. Am. J. Clin. Oncol. 26 ( 4 ), 325 – 331 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA , TherasseP, BogaertsJet al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45 ( 2 ), 228 – 247 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Chen JC , PetrovichZ, GiannottaSL, YuC, ApuzzoML. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain.Neurosurgery46 ( 4 ), 860 – 866 ; discussion 866–867 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Kwon KY , KongDS, LeeJI, NamDH, ParkK, KimJH. Outcome of repeated radiosurgery for recurrent metastatic brain tumors.Clin. Neurol. Neurosurg.109 ( 2 ), 132 – 137 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Powell JW , ChungCT, ShahHRet al. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J. Neurosurg. 109 ( Suppl ), 122 – 128 ( 2008 ).
   PubMedGoogle Scholar
• Li J , BentzenSM, LiJ, RenschlerM, MehtaMP. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.Int. J. Radiat. Oncol. Biol. Phys.71 ( 1 ), 64 – 70 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mariya Y , SekizawaG, MatsuokaY, SekiH, SugawaraT, SasakiY. Repeat stereotactic radiosurgery in the management of brain metastases from non-small cell lung cancer.Tohoku J. Exp. Med.223 ( 2 ), 125 – 131 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Soon YY , ThamIW, LimKH, KohWY, LuJJ. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases.Cochrane Database Syst. Rev.3, CD009454 ( 2014 ).
   PubMedGoogle Scholar
• Lester SC , TakslerGB, KuremskyJGet al. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer 120 ( 3 ), 433 – 441 ( 2014 ).
   PubMedGoogle Scholar
• Lutterbach J , CyronD, HenneK, OstertagCB. Radiosurgery followed by planned observation in patients with one to three brain metastases.Neurosurgery62 ( Suppl. 2 ), 776 – 784 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sheehan JP , YenCP, NguyenJ, RaineyJA, DassoulasK, SchlesingerDJ. Timing and risk factors for new brain metastasis formation in patients initially treated only with gamma knife surgery. Clinical article.J. Neurosurg.114 ( 3 ), 763 – 768 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ribas A , PuzanovI, DummerRet al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, Phase 2 trial. Lancet Oncol. 16 ( 8 ), 908 – 918 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Berghoff AS , RickenG, WidhalmGet al. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. Histopathology 66 ( 2 ), 289 – 299 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Postow MA , CallahanMK, BarkerCAet al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 366 ( 10 ), 925 – 931 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Twyman-Saint Victor C , RechAJ, MaityAet al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520 ( 7547 ), 373 – 377 ( 2015 ).
   PubMed Web of Science ®Google Scholar